Same Indication

Metformin vs Tofacitinib

Metformin vs Tofacitinib: Overview

This comparison examines the pharmacological differences between Metformin and Tofacitinib.

Mechanism of Action

Metformin: Activates AMP-activated protein kinase, decreasing hepatic glucose production.

Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

Pharmacokinetics

Half-life: Metformin — 4-9 hours; Tofacitinib — 3.2 hours.

Chemical Properties

Molecular Formula: Metformin — C4H11N5; Tofacitinib — C16H20N6O.

Molecular Weight: Metformin — 129.1640 g/mol; Tofacitinib — 312.3700 g/mol.

Type: Metformin — Small molecule; Tofacitinib — Small molecule.